Twenty volunteers were trained to discriminate between 75 mg tripelenn
amine (TP) and placebo, During the first four sessions, the drugs were
identified prior to ingestion by letter code, During the next is sess
ions, the procedure was the same except the capsules were not identifi
ed. At the end of the 3-h session, participants indicated which capsul
e they believed they received using the letter codes, When correct, th
ey received a monetary bonus. If they were correct on five sessions, t
hey entered the third phase which had tell additional training and 12
test sessions. During tests, participants received capsules that conta
ined other drugs, including diphenhydramine (50 and 75 mg), chlorpheni
ramine (4 and 6 mg), diazepam (5 and 10 mg), d-amphetamine (5 and 10 m
g), as well as tripelennamine (25, 50 and 75 mg) and placebo. Thirteen
participants learned the discrimination and nine entered the third ph
ase, Except for placebo, most participants identified the test compoun
ds as TP and labeled them as sedatives. TP produced significant change
s on several subjective and physiological measures. The test compounds
produced varied effects which were neither clearly dose-related nor r
elated to the identification as TP or placebo, These results indicate
that tripelennamine call function as a discriminative stimulus, but wi
th little evidence of pharmacological specificity.